Androgen Deprivation and Localized Radiotherapy to Metastases in Patients With Oligometastatic Hormone - Sensitive Prostate Cancer

This page presents selected fields from the linked source record. It does not add a medical interpretation.

Open original source record ↗

Record identity and dates

Source

ClinicalTrials.gov

Source record ID

NCT00544830

Title field or adapter rule

{'original_value': 'Androgen Deprivation and Localized Radiotherapy to Metastases in Patients With Oligometastatic Hormone - Sensitive Prostate Cancer', 'source_field': 'protocolSection.identificationModule.officialTitle'}

Ingested At

2026-11-01T01:03:06.241665+00:00

Published At

2022-04-06T00:00:00+00:00

Record Updated At

2026-10-28

Results Posted At

2022-04-06

Source Retrieved At

2026-11-01T01:03:05.968908+00:00

Timestamp Basis

ClinicalTrials.gov API/RSS response retrieval timestamp recorded by Dossier adapter

Date limitation

ClinicalTrials.gov API/RSS response retrieval timestamp recorded by Dossier adapter

Fields recorded by this source

protocolSection.conditionsModule.conditions

["PSA Level Greater Than Two", "Stage IV Prostate Adenocarcinoma AJCC v7"]

protocolSection.statusModule.lastUpdatePostDateStruct

{"date": "2026-10-28", "type": "ACTUAL"}

protocolSection.identificationModule.nctId

"NCT00544830"

protocolSection.identificationModule.officialTitle

"Androgen Deprivation and Localized Radiotherapy to Metastases in Patients With Oligometastatic Hormone - Sensitive Prostate Cancer"

protocolSection.statusModule.overallStatus

"ACTIVE_NOT_RECRUITING"

protocolSection.designModule.phases

["PHASE2"]

protocolSection.statusModule.resultsFirstPostDateStruct

{"date": "2022-04-06", "type": "ACTUAL"}

Study condition terms

• PSA Level Greater Than Two (protocolSection.conditionsModule.conditions)
• Stage IV Prostate Adenocarcinoma AJCC v7 (protocolSection.conditionsModule.conditions)

Interventions recorded in this study

• {'armGroupLabels': ['Treatment (androgen therapy, radiation therapy)'], 'description': 'Given PO', 'name': 'Bicalutamide', 'type': 'DRUG'} (protocolSection.armsInterventionsModule.interventions[])
• {'armGroupLabels': ['Treatment (androgen therapy, radiation therapy)'], 'description': 'Given SC', 'name': 'Goserelin Acetate', 'type': 'DRUG'} (protocolSection.armsInterventionsModule.interventions[])
• {'armGroupLabels': ['Treatment (androgen therapy, radiation therapy)'], 'description': 'Undergo IMRT', 'name': 'Intensity-Modulated Radiation Therapy', 'type': 'RADIATION'} (protocolSection.armsInterventionsModule.interventions[])
• {'armGroupLabels': ['Treatment (androgen therapy, radiation therapy)'], 'description': 'Correlative studies', 'name': 'Laboratory Biomarker Analysis', 'type': 'OTHER'} (protocolSection.armsInterventionsModule.interventions[])
• {'armGroupLabels': ['Treatment (androgen therapy, radiation therapy)'], 'description': 'Given via injection', 'name': 'Leuprolide Acetate', 'type': 'DRUG'} (protocolSection.armsInterventionsModule.interventions[])

An intervention appearing in a study record does not establish an effect or an approved use.

Drug names recorded in this source

• Bicalutamide (protocolSection.armsInterventionsModule.interventions[].name)
• Goserelin Acetate (protocolSection.armsInterventionsModule.interventions[].name)
• Leuprolide Acetate (protocolSection.armsInterventionsModule.interventions[].name)

A recorded drug name is not by itself an indication or a condition-specific relationship.

This index keeps the source fields it imported; it may not contain the complete original record. Verify wording and context in the linked source.